The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury

Cell Death and Disease

Volumn 1, Issue 11, 2010, Pages

  Lanzillotta, A ^a   Sarnico, I ^a   Ingrassia, R ^b   Boroni, F ^a   Branca, C ^a   Benarese, M ^a   Faraco, G ^c   Blasi, F ^c   Chiarugi, A ^c   Spano, P ^a   Pizzi, M ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Ischemic preconditioning; MCAO; OGD; RelA acetylation

Indexed keywords

ARGININE; BIM PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; LYSINE 310; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; MEMBRANE PROTEIN; ONCOPROTEIN;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL DEATH; CELL LOSS; DEACYLATION; HUMAN; HUMAN CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CHEMISTRY; GENETICS; METABOLISM; PATHOLOGY;

MUS;

ACETYLATION; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN ISCHEMIA; CREB-BINDING PROTEIN; INFARCTION, MIDDLE CEREBRAL ARTERY; LYSINE; MEMBRANE PROTEINS; MICE; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENE PROTEINS; SIRTUIN 1; TRANSCRIPTION FACTOR RELA;

EID: 79958719815     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.76     Document Type: Article

References (42)

1. Clemens JA, Stephenson DT, Smalstig EB, Dixon EP, Little SP. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke 1997; 28: 1073-1080.
2. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999; 5: 554-559. (Pubitemid 29220215)
3. Nurmi A, Perttu J, Koistinaho M, Zhang W, Juettler E, Karjalainem-Lindsberg ML et al. Nuclear factor-kB contributes to infarction after permanent focal ischemia. Stroke 2004; 35: 987-991. (Pubitemid 38419815)
4. Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J et al. IKK mediates ischemia-induced neuronal death. Nat Med 2005; 11: 1322-1329. (Pubitemid 41752913)
5. Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F et al. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 30-40. (Pubitemid 40096895)
6. Crack PJ, Taylor JM, Ali U, Mansell A, Hertzog PJ. Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury. Stroke 2006; 37: 1533-1538. (Pubitemid 44305738)
7. Inta I, Paxian S, Zhang W, Pizzi M, Sarnico I, Spano P et al. Bim and Noxa are candidates to mediate the deleterious effect of the NF-kB subunit RelA in cerebral ischemia. J Neurosci 2006; 26: 12896-12903. (Pubitemid 44954609)
8. Sarnico I, Lanzillotta A, Boroni F, Benarese M, Alghisi M, Schwaninger M et al. NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. J Neurochem 2009; 108: 475-485.
9. Valerio A, Dossena M, Bertolotti P, Boroni F, Sarnico I, Faraco G et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/ c-Rel-dependent transcription. Stroke 2009; 40: 610-617.
10. Pizzi M, Sarnico I, Boroni F, Benarese M, Steimberg N, Mazzoleni G et al. NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Diff 2005; 12: 761-772. (Pubitemid 40945983)
11. Bhakar AL, Tannis LL, Zeindler C, Russo MP, Jobin C, Park DS et al. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 2002; 22: 8466-8475. (Pubitemid 35387587)
12. Gutierrez H, Hale VA, Dolcet X, Davies A. NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development 2005; 132: 1713-1726. (Pubitemid 40575870)
13. West AE, Griffith EC, Greenberg ME. Regulation of transcription factors by neuronal activity. Nat Rev Neurosci 2002; 3: 921-931. (Pubitemid 135715879)
14. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 2003; 6: 1072-1078. (Pubitemid 37186199)
15. Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prüllage M et al. NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol 2006; 26: 2936-2946.
16. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappa B is a key event in brain tolerance. J Neurosci 2001; 21: 4668-4677. (Pubitemid 32565625)
17. Chen LF, Greene WC. Shaping the nuclear action of NF-kB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
18. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 2004; 13: 853-865. (Pubitemid 38438480)
19. Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB. EMBO J 2002; 21: 6539-6548. (Pubitemid 35448431)
20. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L et al. NF-κB phosphorylation regulates RelA acetylation. Mol Cell Biol 2005; 25: 7966-7975. (Pubitemid 41262991)
21. Yang XD, Tajkorshis E, Chen LF. Functional interplay between acetylation and methylation of the RelA subunit of NF-kB. Mol Cell Biol 2010; 30: 2170-2180.
22. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380. (Pubitemid 38954844)
23. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005; 280: 40364-40374. (Pubitemid 41779174)
24. Faraco G, Blasi F, Min W, Wang ZQ, Moroni F, Chiarugi A. Brain ischemic preconditioning does not require PARP-1. Stroke 2010; 41: 181-183.
25. Pizzi M, Boroni F, Bianchetti A, Moraitis C, Sarnico I, Benarese M et al. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur J Neurosci 2002; 16: 2342-2350. (Pubitemid 36056959)
26. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci 2002; 22: 5423-5431. (Pubitemid 35386464)
27. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. H3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005; 17: 525-535. (Pubitemid 40269117)
28. Puthalakath H, Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 2002; 9: 505-512. Review. (Pubitemid 34521178)
29. Zhang L, Xing D, Chen M. Bim(L) displacing Bcl-x(L) promotes Bax translocation during TNFalpha-induced apoptosis. Apoptosis 2008; 13: 950-958.
30. Li D, Qu Y, Mao M, Zhang X, Li J, Ferriero D et al. Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab 2009; 29: 1903-1913.
31. Okuno S, Saito A, Hayashi T, Chan PH. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci 2004; 24: 7879-7887. (Pubitemid 39215692)
32. Gao Y, Signore AP, Yin W, Cao G, Yin XM, Sun F et al. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab 2005; 25: 694-712. (Pubitemid 40705605)
33. Chariot A. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 2009; 19: 404-413.
34. Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR et al. The NF-kappaBmediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ 2006; 13: 712-729.
35. Wang J, Wang X, Hussain S, Zheng Y, Sanjabi S, Ouaaz F et al. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J Immunol 2007; 178: 6777-6788. (Pubitemid 46847402)
36. Huang B, Yang XD, ZhouMM, Ozato K, Chen LF. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol 2009; 29: 1375-1387.
37. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007; 26: 3169-3179. (Pubitemid 47057498)
38. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ et al. Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 2008; 15: 1545-1551. (Pubitemid 351997786)
39. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015. (Pubitemid 38393275)
40. Granja AG, Sabina P, Salas ML, Fresno M, Revilla Y. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. J Virol 2006; 80: 10487-10496. (Pubitemid 44628895)
41. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 861-870. (Pubitemid 351600664)
42. Saha RN, Jana M, Pahan K. MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol 2007; 179: 7101-7109.